Company Overview - Synergy CHC Corp. is a fast-growing consumer health and wellness company, providing products aimed at improving health and wellness [3] Upcoming Financial Results - The company plans to release its financial results for the second quarter ended June 30, 2025, on August 14, 2025, before market trading opens [1] - A conference call will be held at 9:00 a.m. ET / 6:00 a.m. PT with CEO Jack Ross and CFO Jaime Fickett to discuss the results [2] Product Portfolio - Synergy's brand portfolio includes FOCUSfactor, a clinically studied brain health supplement that enhances memory, concentration, and focus, and Flat Tummy, a lifestyle brand focused on women's wellness and weight management [3]

Core Insights - Synergy CHC Corp. has announced significant retail and distribution wins for its FOCUSfactor supplement and functional beverage lines, reflecting a focused strategy to scale its cognitive health portfolio [1][2] Supplement Gains - London Drugs will launch FOCUSfactor brain health supplements across all 80 store locations in Western Canada starting this summer, targeting a growing health and wellness consumer base [3][4] - Synergy has secured a national distribution agreement with McKesson Canada, allowing access to thousands of pharmacy and health-focused retail locations across Canada, with a rollout scheduled for Q4 2025 [4][5] Beverage Gains - Gabe's will introduce FOCUSfactor Focus + Energy beverages to 137 stores in the Mid-Atlantic and Southeast, with additional exposure through Old Time Pottery's 34 stores, totaling 171 retail locations across 20 states [5][6] - FOCUSfactor will showcase its beverage line at the 2025 ECRM Beverage Show in Dallas, meeting with over 25 national retailers and distributors representing over 32,000 doors across the USA [6][7] Building Momentum - The recent distribution wins follow a series of major agreements earlier this year, indicating accelerating momentum across both product lines and key regions, with expectations for further updates in the coming months [8]

Core Viewpoint - Synergy CHC Corp. has secured a $20 million term loan credit agreement to enhance its capital structure and support growth initiatives [1][3]. Financial Details - The company received a $15 million term loan at closing with an interest rate of SOFR plus 8.5%, structured as interest-only through 2025 [2]. - Quarterly principal payments will commence in January 2026 at $175,000, increasing to $350,000 per quarter in 2027 and beyond [2]. - Additionally, a $2.5 million delayed draw facility and a $2.5 million uncommitted term loan incremental facility are available [2]. Strategic Implications - The CEO of Synergy emphasized that the refinancing supports the company's growth strategy and strengthens its capital structure, providing necessary flexibility for future growth [3]. - The delayed draw proceeds will enable the company to repay debt related to settlement agreements, enhancing financial stability as it pursues strategic goals [3]. Company Overview - Synergy CHC Corp. specializes in consumer health care and lifestyle products, with notable brands including FOCUSfactor, a brain health supplement, and Flat Tummy, a wellness brand focused on nutritional products for weight management [4].

Core Insights - Synergy CHC Corp. has appointed Erik Shields as Vice President of Beverage, effective May 26, 2025, to enhance its beverage business strategy [1][2] - Shields brings nearly 20 years of experience in sales leadership within both alcoholic and non-alcoholic beverage sectors, previously serving as Director of C-Store Sales at Trilliant Food & Nutrition [2][3] - The company is focusing on expanding its flagship brain health brand, FOCUSfactor, into the functional beverage category with the launch of Focus + Energy Drinks, which are designed to meet rising consumer demand for health-oriented beverage options [3][5] Company Strategy - The appointment of Erik Shields is seen as a strategic move to accelerate growth in the beverage category, leveraging his expertise in national strategies and key account management [2][4] - Shields will oversee the go-to-market strategy, distribution, and brand execution for the new Focus + Energy Drinks, aligning with trends in mental performance and functional beverages [3][4] - Synergy's current brand portfolio includes FOCUSfactor, a brain health supplement, and Flat Tummy, a wellness brand aimed at women's nutritional needs [5]

Core Insights - Synergy CHC Corp. reported a 30% year-over-year growth in earnings per share, marking its ninth consecutive quarter of profitability [2] - The company expanded its EBITDA margins to 24.1%, up from 19.7% in the prior year, indicating strong operational performance [2] - Synergy is preparing for international expansion into three new markets and is refinancing its debt to enhance cash flow and extend maturity to 2029 [2] Financial Performance - Revenue for Q1 2025 was $8.2 million, a decrease of 13% from $9.4 million in Q1 2024, primarily due to a non-repeating product sell-in [5] - Gross margin improved to 75.4% from 72.0% year-over-year, driven by a favorable product mix [5] - Operating expenses decreased by 15% to $4.2 million from $5.0 million in the same period last year [6] - Income from operations increased by 8% to $1.9 million compared to $1.8 million in Q1 2024 [6] - Net income rose by 51% to $876.3 thousand from $580.5 thousand year-over-year [7] - EBITDA for Q1 2025 was $1.98 million, up 7% from $1.85 million in Q1 2024, attributed to lower SG&A expenses [7] Balance Sheet and Cash Flow - As of March 31, 2025, cash and cash equivalents were approximately $177.9 thousand, down from $687.9 thousand at the end of 2024 [10] - Total liabilities decreased to $31.3 million from $33.0 million, reflecting a reduction of $1.7 million [10] - Inventory increased to $2.3 million from $1.7 million as of December 31, 2024 [10] - Cash used in operating activities was $822.8 thousand, slightly improved from $858 thousand in Q1 2024 [11] Business Developments - Synergy established a wholly owned subsidiary in Mexico and is onboarding key suppliers and retailers in the region [9] - The company signed a new long-term supplier agreement for FOCUSfactor products, effective April 2025, expected to yield significant cost savings [9] - During Q1, Synergy reduced outstanding liabilities by $1.7 million [9]

Company Overview - Synergy CHC Corp. is a provider of consumer health care and lifestyle products [3] - The company's brand portfolio includes FOCUSfactor, a clinically-tested brain health supplement, and Flat Tummy, a wellness brand focused on nutritional products for weight management [3] Financial Results Announcement - Synergy plans to release its financial results for the first quarter ended March 31, 2025, on May 15, 2025, before market trading opens [1] - A conference call will be held at 9:00 a.m. ET / 6:00 a.m. PT with the CEO Jack Ross and CFO Jaime Fickett [2] - A live webcast of the call will be available on the Investor Relations section of Synergy's website, and a replay will be accessible for a limited time [2]

Core Insights - Synergy CHC Corp. reported its financial results for the year ending December 31, 2024, highlighting a continued profitability streak with eight consecutive profitable quarters despite challenges in the fourth quarter due to retailer de-inventorying related to the FOCUSfactor packaging transition [2][6]. Financial Performance - Fourth quarter revenue was $10.3 million, a decrease of 22% from $13.2 million in Q4 2023. Full year revenue was $34.8 million, down 19% from $42.8 million in 2023 [6]. - Gross margin for Q4 2024 was 63.3%, down from 82.3% in Q4 2023. For the full year, gross margin was 67.9%, a decline of 712 basis points from 75.0% in 2023 [7]. - Income from operations in Q4 2024 was $1.4 million compared to $4.4 million in Q4 2023. For the full year, it was $5.8 million, down from $10.8 million in 2023 [10]. - Net income for Q4 2024 was $105.7 thousand, a significant drop from $2.6 million in Q4 2023. Full year net income was $2.1 million compared to $6.3 million in 2023 [11]. - EBITDA for Q4 2024 was $1.7 million, down from $4.5 million in Q4 2023. For the full year, EBITDA was $6.5 million compared to $10.8 million in 2023 [12]. - Adjusted EBITDA for Q4 2024 was $2.8 million, a substantial increase of 1,033% from $(0.3) million in Q4 2023. For the full year, Adjusted EBITDA was $7.4 million, up 21% from $6.1 million in 2023 [13]. Business Developments - The company successfully rebranded FOCUSfactor and expanded its distribution with BJ's Wholesale Club and Publix, with FOCUSfactor products now available in all 267 BJ's locations and 1,200 Publix stores [6]. - In Q1 2025, Synergy launched seven new products under the Flat Tummy brand, targeting the growing interest in GLP-1 support products [2]. - The company completed its Initial Public Offering (IPO) in October 2024, issuing 1,150,000 shares at $9.00 per share, with trading commencing on the Nasdaq Global Market under the ticker symbol "SNYR" [6]. Balance Sheet and Cash Flow - As of December 31, 2024, Synergy had approximately $687.9 thousand in cash and cash equivalents, an increase from $632.5 thousand as of December 31, 2023. Total liabilities decreased to $33.0 million from $39.5 million [14]. - The company reduced outstanding debt by $4.5 million during the fourth quarter [6]. - Cash used in operating activities for the year ended December 31, 2024, was $4.8 million, a decline from cash provided by operating activities of $421.7 thousand in 2023 [15].